MMSI (Merit Medical Systems) LT-Debt-to-Total-Asset : 0.32 (As of Dec. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Merit Medical Systems LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Merit Medical Systems's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.32.

Merit Medical Systems's long-term debt to total assets ratio declined from Dec. 2023 (0.38) to Dec. 2024 (0.32). It may suggest that Merit Medical Systems is progressively becoming less dependent on debt to grow their business.

Merit Medical Systems LT-Debt-to-Total-Asset Historical Data

The historical data trend for Merit Medical Systems's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merit Medical Systems LT-Debt-to-Total-Asset Chart

Merit Medical Systems Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.25

0.18

0.15

0.38

0.32

Merit Medical Systems Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.38	0.37	0.36	0.34	0.32

Merit Medical Systems LT-Debt-to-Total-Asset Calculation

Merit Medical Systems's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	784.334	/	2418.603
	=	0.32

Merit Medical Systems's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	784.334	/	2418.603
	=	0.32

Merit Medical Systems (NAS:MMSI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Merit Medical Systems LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Merit Medical Systems's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Merit Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Merit Medical Systems Inc (NAS:MMSI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

MM3:Germany

Address

1600 West Merit Parkway, South Jordan, UT, USA, 84095

Website

https://www.merit.com

Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.

Executives

Fred P Lampropoulos	director, officer: President & CEO
Brian G. Lloyd	officer: Chief Legal Officer, Secretary	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Raul Jr. Parra	officer: Interim CFO	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Stephen C. Evans	director	C/O ALARM.COM HOLDINGS, INC., 8281 GREENSBORO DRIVE, SUITE 100, TYSONS VA 22102
Neil Peterson	officer: Chief Operating Officer	1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michel James Voigt	officer: Chief Human Resources Officer	1600 W MERIT PARKWAY, SOUTH JORDAN UT 84095
F. Ann Millner	director	4275 SPRING ROAD, OGDEN UT 84403
Joseph Wright	officer: President, International	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Thomas James Gunderson	director	5905 LONG BRAKE TRAIL, EDINA MN 55439
A Scott Anderson	director	ONE SOUTH MAIN, SUITE 1134, SALT LAKE CITY UT 84111
Lynne Ward	director	1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095
Ronald Frost	officer: Chief Operating Officer	1600 WEST MERIT PARKWAY, SOUTH JORDAN X1 84095
Robert Fredericks	officer: Chief Strategy & Innovation O.	1600 MERIT PARKWAY, SOUTH JORDAN UT 84095
Michael R Mcdonnell	director	C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Laura S. Kaiser	director	10101 WOODFIELD LANE, ST. LOUIS MO 63132